• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line.

作者信息

Kraker A J, Moore C W

机构信息

Department of Chemotherapy, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105.

出版信息

Cancer Lett. 1988 Jan;38(3):307-14. doi: 10.1016/0304-3835(88)90022-5.

DOI:10.1016/0304-3835(88)90022-5
PMID:3349449
Abstract

The activity of DNA polymerase beta, which is an enzyme involved in repair of DNA damage, was assessed in P388 murine leukemia cell lines sensitive and resistant to cis-diamminedichloroplatinum(II) (cis-Pt). The resistant line was selected with cis-Pt and showed cross-resistance to a number of alkylating agents, but not to an anthracycline. The DNA polymerase beta activity was found to be elevated 5-fold in the resistant line based upon activity per mg cell protein and elevated 4-fold based upon activity per 10(7) cells. The characterization of elevated activity of an enzyme active in DNA repair in a cell line resistant to DNA damaging agents describes a possible mechanism of resistance in addition to those previously found.

摘要

相似文献

1
Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line.
Cancer Lett. 1988 Jan;38(3):307-14. doi: 10.1016/0304-3835(88)90022-5.
2
The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum(II) and related derivatives.
Anticancer Res. 1989 Jul-Aug;9(4):915-22.
3
Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.对氨甲蝶呤耐药的P388白血病亚系的特性:拓扑异构酶II功能改变的证据。
Mol Pharmacol. 1987 Jul;32(1):17-25.
4
Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.对阿霉素的多因素抗性:阿霉素敏感和抗性P388白血病克隆细胞系中DNA修复、谷胱甘肽转移酶活性、药物外排和P-糖蛋白的关系。
Cancer Res. 1988 Jul 1;48(13):3595-602.
5
Dihydrofolate reductase activity in adriamycin and methotrexate sensitive and resistant P388 leukemia cells.阿霉素和甲氨蝶呤敏感及耐药的P388白血病细胞中的二氢叶酸还原酶活性
Cell Biol Int Rep. 1987 May;11(5):389-96. doi: 10.1016/0309-1651(87)90006-3.
6
Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.小鼠白血病细胞系对顺二氯二氨铂(II)获得性耐药的特征分析
Jpn J Cancer Res. 1992 Feb;83(2):219-25. doi: 10.1111/j.1349-7006.1992.tb00089.x.
7
The relationship of the proliferating cell nuclear antigen protein to cis-diamminedichloroplatinum (II) resistance of a murine leukemia cell line P388/CDDP.
Oncology. 1991;48(3):234-8. doi: 10.1159/000226934.
8
Platinum incorporation and differential effects of cis- and trans-diamminedichloroplatinum(II) on the growth of mouse leukemia P388/D1.
Cancer Res. 1989 Dec 15;49(24 Pt 1):7072-7.
9
Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells.多柔比星耐药小鼠白血病P388细胞中的谷胱甘肽S-转移酶和谷胱甘肽过氧化物酶
Biochem Pharmacol. 1989 Oct 15;38(20):3505-10. doi: 10.1016/0006-2952(89)90121-4.
10
Role of carrier ligand in platinum resistance of human carcinoma cell lines.载体配体在人癌细胞系铂耐药中的作用。
Cancer Res. 1993 Feb 15;53(4):799-805.

引用本文的文献

1
Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion.结构洞察主要顺铂诱导的 DNA 损伤的促突变旁路。
Biochem J. 2020 Mar 13;477(5):937-951. doi: 10.1042/BCJ20190906.
2
Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.通过贝叶斯统计建模预测乳腺癌细胞中导致获得性耐药的信号串扰。
BMC Syst Biol. 2015 Jan 20;9:2. doi: 10.1186/s12918-014-0135-x.
3
Structural basis for the inefficient nucleotide incorporation opposite cisplatin-DNA lesion by human DNA polymerase β.
人源 DNA 聚合酶 β 催化顺铂-DNA 加合物时,核苷酸掺入效率低下的结构基础。
J Biol Chem. 2014 Nov 7;289(45):31341-8. doi: 10.1074/jbc.M114.605451. Epub 2014 Sep 18.
4
Lack of in vivo cross-resistance with 4'-thio-ara-C against drug-resistant murine P388 and L1210 leukemias.体内缺乏 4'-硫代阿糖胞苷对耐药鼠 P388 和 L1210 白血病的交叉耐药性。
Cancer Chemother Pharmacol. 2011 Aug;68(2):399-403. doi: 10.1007/s00280-010-1498-3. Epub 2010 Nov 11.
5
Characterization of DNA polymerase beta mutants with amino acid substitutions located in the C-terminal portion of the enzyme.对DNA聚合酶β突变体的特性研究,这些突变体的氨基酸替换位于该酶的C末端部分。
Mol Gen Genet. 1995 Jul 28;248(2):217-24. doi: 10.1007/BF02190803.
6
Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents.通过反义RNA对DNA聚合酶β进行策略性下调可使哺乳动物细胞对特定的DNA损伤剂敏感。
Nucleic Acids Res. 1995 Oct 11;23(19):3810-5. doi: 10.1093/nar/23.19.3810.
7
Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia.顺铂耐药小鼠P388白血病体内抗肿瘤药物交叉耐药性
Cancer Chemother Pharmacol. 1991;27(6):456-63. doi: 10.1007/BF00685160.
8
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.顺二氯二氨合铂(II)耐药性的调控:综述
Br J Cancer. 1992 Aug;66(2):227-38. doi: 10.1038/bjc.1992.249.
9
Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.盐酸卡美噻唑在小鼠临床前模型中的抗肿瘤活性及交叉耐药性
Cancer Chemother Pharmacol. 1992;30(4):261-6. doi: 10.1007/BF00686292.